Coverage
-
January 11, 2021
The U.S. Supreme Court on Monday shot down Bristol-Myers Squibb and Sanofi's challenge to a decision that allowed New Mexico to proceed with allegations of unlawful drug marketing even though a whistleblower lost a suit with the same facts.
1 other articles on this case.
View all »